Global High-flow Nasal Cannula Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global High-flow Nasal Cannula Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

High-flow nasal cannula (HFNC) oxygen therapy is carried out using an air/oxygen blender, active humidifier, single heated tube, and nasal cannula. Able to deliver adequately heated and humidified medical gas at flows up to 60 L/min, it is considered to have a number of physiological advantages compared with other standard oxygen therapies, including reduced anatomical dead space, PEEP, constant FIO2, and good humidification.

Market Overview:

The latest research study on the global High-flow Nasal Cannula market finds that the global High-flow Nasal Cannula market reached a value of USD 3114.74 million in 2022. It’s expected that the market will achieve USD 3963.92 million by 2028, exhibiting a CAGR of 4.1% during the forecast period.

Influence of COVID-19 Outbreak on High-flow Nasal Cannula Industry Development

Market demand increases
In recent years, High-flow Nasal Cannula has been rapidly popularized in clinical practice, and its clinical efficacy has been widely recognized by clinicians. In recent years, many prospective clinical studies with large samples have been published in famous international journals, which proves the therapeutic value of High-flow Nasal Cannula equipment in hypoxemia and mild to moderate simple hypoxic respiratory failure (type I respiratory failure).
Compared with traditional oxygen therapy, high-flow nasal canula (HFNC) has great advantages in acute hypoxic respiratory failure, which can reduce the intubation rate and 90-day mortality, and has played an important role in the treatment of MERS-CoV pneumonia and H1N1 pneumonia.
At present, HFNC also plays an important role in the treatment of severe and critical patients in novel coronavirus (NCP).
Therefore, high-flow nasal Cannula industry equipment is an urgent product to deal with the epidemic. Resulting in increasing demand in downstream market.

Supply of raw materials is tight

Affected by COVID-19, the logistics speed in most areas slowed down, and the supply of raw materials in the high-flow nasal cannula industry was tight. The downstream demand increased, and the supply of raw materials was relatively insufficient, which greatly affected the production of related enterprises in the hardest hit areas. Short-term epidemic has little impact on raw material supply of enterprises, mainly consuming inventory materials, while long-term epidemic will cause incalculable losses. If the epidemic develops further, the logistics will always be unsatisfactory, and small and medium-sized enterprises with high-flow nasal cannula will probably close down due to insufficient supply of raw materials, and even large enterprises will face the same problem.

Market Driver Analysis

Increased downstream demand High-Flow Nasal Cannula has the functions of reducing inhalation resistance, flushing nasopharyngeal anatomy dead space, reducing metabolic work related to gas regulation, improving airway conductivity and mucosal ciliary clearance, and providing low levels of positive airway pressure. And widely used in respiratory diseases and chronic lung diseases. Because the newborn's respiratory organs and functions are immature, it is also a high incidence stage of respiratory diseases. A common respiratory disease in newborns is neonatal pneumonia. The worldwide spread of COVID-19 in recent two years has also increased the demand for high-flow nasal cannula. Secondly, with the development of technology, the High-Flow Nasal Cannula equipment will be more complete and can meet more needs. Therefore, the increase in respiratory diseases and the development of new technologies are one of the important factors driving the global market for high-flow nasal cannula.
Health industry development People's health awareness has been enhanced and medical systems in various countries have been continuously improved, and policies related to medical security have also benefited the market. In most developed countries and some developing countries, universal health insurance has either been achieved or is a policy that governments of various countries are pushing hard. At the same time, the COVID-19 epidemic has brought great pressure on the labor force, infrastructure and supply chain of the global medical industry, and exposed the problem of unequal social medical resources. At the same time, it accelerates the change of industry ecosystem, forcing public and private medical systems to adapt and innovate in a short time. People's awareness of health is also rising. In addition, the developing healthcare industry in Asia is creating better opportunities for important market participants to expand their business. It is expected that emerging markets in Asia Pacific will have a positive impact on market growth in the forecast year.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

Fisher & Paykel Healthcare is one of the major players operating in the High-flow Nasal Cannula market, holding a share of 24.34% in 2021.

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in more than 120 countries worldwide.

ResMed pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. ResMed cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases. ResMed comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, ResMed improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

Segmentation Overview:

By type, Nasal Cannulas segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global High-flow Nasal Cannula market covered in Chapter 3:

Hamilton Medical
Vyaire Medical
TNI Medical AG
Teleflex Incorporated
Salter Labs
Vapotherm
ResMed
Flexicare Medical Limited
Fisher & Paykel Healthcare
Koninklijke Philips
Great Group Medical

In Chapter 4 and Chapter 14.2, on the basis of types, the High-flow Nasal Cannula market from 2018 to 2029 is primarily split into:

Air/Oxygen Blender
Nasal Cannulas
Active Humidifier
Single Heated Tube
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the High-flow Nasal Cannula market from 2018 to 2029 covers:

Hospitals
Clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)